Topical application of clobetasol propionate in a strength of 0 05% in cream or ointment (Dermovate) suppressed the hypothalamic-pituitary-adrenal axis in both normal people and patients with diseased skin. In normal people the 9 am serum cortisol level was suppressed when between 45 and 90 g was applied weekly. Insulin stress test results in patients with diseased skin showed an abnormally small response after long-term application of similar amounts. We conclude that long-term administration should be restricted to less than 50 g a week.
Discussion
Our data agree with previous reports2-5 that topically applied clobetasol propionate in a strength of 0 05% (Dermovate) may cause profound suppression of the HPA axis. Normal people applying 45 g clobetasol propionate cream weekly did not show significant suppression, whereas all but one of those applying 90 g weekly showed profound suppression. This suggests that in most normal people the "safe" threshold for the amount applied weekly lies between 45 and 90 g. We are unable to explain why one of the normal people failed to suppress at all with 90 g weekly and feel that this represents individual variation in the handling of the drug. Because of this we suspect that a few patients may be able to apply large amounts of the drug without developing features of Cushing's syndome. But, as our data on patients show, in most cases there appeared to be a linear relationship between the amount of the preparation applied and HPA axis suppression. Patients applying over 50 g weekly all had either a reduced 9 am serum cortisol level or a reduced peak insulin stress test level. Those using over 100 g weekly showed profound suppression and developed features of Cushing's syndrome. On withdrawal they suffered symptoms of adrenocortical insufficiency and developed pustular psoriasis.
Patients find preparations of clobetasol propionate gratifyingly effective for treating their stubborn dermatoses, especially psoriasis. They also appreciate the euphoriant effect, hence overenthusiastic application is particularly apt to occur. We conclude that patients should be warned against using more than 50 g a week. Their physicians should exercise as much caution with this cream as with systemic corticosteroids.
SHORT REPORTS Infusion apparatus for parenteral nutrients
The use of parenteral nutrition is achieving wide acceptance in many acute medical and surgical situations. To provide total parenteral nutrition for seriously ill patients the infusion of several nutrient solutions simultaneously may be required to provide daily metabolic requirements. Numerous studies have confirmed that the concomitant use of amino-acids with carbohydrate or fat emulsion provides a utilizable anabolic protein source for parenteral nutrition regimens.' Increased efficiency of a parenteral diet is achieved when the calories are provided by both carbohydrate and fat,2 and optimal metabolic usage requires that carbohydrates, potassium, and amino-acid sources be administered simultaneously.3 4 Many ill patients lose abnormal amounts of body fluids, and often require additional water and electrolyte supplements, together with vitamins and minerals. In patients with high metabolic demands, insulin and glucose regimens provide a valuable additional approach to the problem., The problems ofchemical incompatibility between these various solutions and the risks of infection when such solutions are mixed have restricted the choice of suitable regimens available to clinicians. We describe an apparatus designed to overcome the problems of multiple intravenous fluid infusions.
Design of Apparatus
The system we have developed(see fig) allows great flexibility in prescribing intravenous solutions for seriously ill patients, whose metabolic requirements may be constantly changing. Though any combination of solutions can be used with this apparatus within the limitations of chemical compatibility, we describe a typical regimen for complete intravenous nutrition which has proved satisfactory in practice.
Bottles 1 and 2 contain amino-acid solutions and a calorie source respectively. The following solutions have been used concurrently and found to be compatible: amino-acid solutions-Aminoplex-14, Vamin, Trophysan, and Aminosol; calorie solutions-sorbitol, hypertonic glucose, fructose, and Intralipid. Bottle 3 contains normal saline or dextrose 5%, with additional potassium supplements and multivitamin solutions as required. Bottle 4
